Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus

Journal of Clinical Lipidology

Volumn 6, Issue 4, 2012, Pages 318-324

  Goldberg, Ronald B ^a   Rosenson, Robert S ^b   Hernandez Triana, Eric ^c   Misir, Soamnauth ^d   Jones, Michael R ^d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD DEL ROSARIO   (Colombia)

^d DAIICHI SANKYO INC   (United States)

Author keywords

Apolipoprotein; Bile acid sequestrant; Colesevelam; Lipoprotein particles; Low density lipoprotein; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN B; CHYLOMICRON; COLESEVELAM; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLYLAMINE; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; METFORMIN; MIDDLE AGED; PLACEBO EFFECT; TRIGLYCERIDES;

EID: 84864216037     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.05.005     Document Type: Article

References (31)

1. H.E. Bays, R.B. Goldberg, K.E. Truitt, and M.R. Jones Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects Arch Intern Med 168 2008 1975 1983
2. V.A. Fonseca, J. Rosenstock, A.C. Wang, K.E. Truitt, and M.R. Jones Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy Diabetes Care 31 2008 1479 1484
3. R.B. Goldberg, V.A. Fonseca, K.E. Truitt, and M.R. Jones Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy Arch Intern Med 168 2008 1531 1540
4. J.D. Brunzell, M. Davidson, C.D. Furberg, R.B. Goldberg, B.V. Howard, J.H. Stein, and J.L. Witztum Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation Diabetes Care 31 2008 811 822
5. R.M. Krauss Lipids and lipoproteins in patients with type 2 diabetes Diabetes Care 27 2004 1496 1504 (Pubitemid 38680002)
6. S. Mora, J.D. Otvos, R.S. Rosenson, A. Pradhan, J.E. Buring, and P.M. Ridker Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women Diabetes 59 2010 1153 1160
7. K. El Harchaoui, W.A. van der Steeg, and E.S. Stroes Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study J Am Coll Cardiol 49 2007 547 553 (Pubitemid 46177441)
8. W.C. Cromwell, and J.D. Otvos Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl Am J Cardiol 98 2006 1599 1602 (Pubitemid 44827965)
9. W.T. Garvey, S. Kwon, and D. Zheng Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 52 2003 453 462 (Pubitemid 36173203)
10. R.S. Rosenson, S.L. Abby, and M.R. Jones Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes Atherosclerosis 204 2009 342 344
11. R.A. DeFronzo, and A.M. Goodman Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group N Engl J Med 333 1995 541 549
12. R. Goldberg, M. Temprosa, and J. Otvos Abstract 1081: Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program Circulation 120 2009 S442
13. J. Rosenstock, V.A. Fonseca, and W.T. Garvey Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes Endocr Pract 16 2010 629 640
14. M.R. Jones, S. Mudaliar, and E. Hernandez-Triana Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes Curr Med Res Opin 25 2009 2239 2249
15. J.D. Otvos, E.J. Jeyarajah, D.W. Bennett, and R.M. Krauss Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement Clin Chem 38 1992 1632 1638
16. G.J. Blake, J.D. Otvos, N. Rifai, and P.M. Ridker Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women Circulation 106 2002 1930 1937 (Pubitemid 35176297)
17. S. Mora, J.D. Otvos, N. Rifai, R.S. Rosenson, J.E. Buring, and P.M. Ridker Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women Circulation 119 2009 931 939
18. M. Rizzo, V. Pernice, and A. Frasheri Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome Clin Endocrinol 70 2009 870 875
19. S. Mora, M. Szklo, and J.D. Otvos LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis 192 2007 211 217 (Pubitemid 46602300)
20. J.D. Otvos, D. Collins, and D.S. Freedman Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial Circulation 113 2006 1556 1563 (Pubitemid 43739414)
21. R.S. Rosenson Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia Atherosclerosis 185 2006 327 330
22. J.R. McNamara, H. Campos, and J.M. Ordovas Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study Arteriosclerosis 7 1987 483 490 (Pubitemid 17145664)
23. U. Beil, J.R. Crouse, K. Einarsson, and S.M. Grundy Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides Metabolism 31 1982 438 444 (Pubitemid 12155449)
24. H. Hirokane, M. Nakahara, S. Tachibana, M. Shimizu, and R. Sato Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4 J Biol Chem 279 2004 45685 45692 (Pubitemid 39491557)
25. M. Guerin, W. Le Goff, T.S. Lassel, A. Van Tol, G. Steiner, and M.J. Chapman Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia Arterioscler Thromb Vasc Biol 21 2001 282 288 (Pubitemid 32125379)
26. A. Zambon, M.A. Austin, B.G. Brown, J.E. Hokanson, and J.D. Brunzell Effect of hepatic lipase on LDL in normal men and those with coronary artery disease Arterioscler Thromb 13 1993 147 153 (Pubitemid 23056787)
27. M.A. Ford, J.P. McConnell, and S. Lavi Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy Atherosclerosis 207 2009 111 115
28. Mackey RH, Greenland P, Goff Jr. DC, et al. The relationship of HDL cholesterol and HDL particles to carotid atherosclerosis and incident cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. Presented at the American Heart Association Cardiovascular Disease Epidemiology and Prevention 2011 Scientific Sessions; March 23-25, 2011; Atlanta, GA, p. 331.
29. A.J. Carrilho, W.L. Medina, E.R. Nakandakare, and E.C. Quintao Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine Clin Pharmacol Ther 62 1997 82 88 (Pubitemid 27327102)
30. D.J. Rader Liver X receptor and farnesoid X receptor as therapeutic targets Am J Cardiol 100 2007 n15 n19
31. C.L. Roumie, M.M. Huizinga, and X. Liu The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort Pharmacoepidemiol Drug Saf 20 2011 36 44